Johnson & Johnson (NYSE: JNJ) has asked U.S. regulators to approve its nasal spray Spravato as a standalone treatment for adults with treatment-resistant depression, the company announced Monday. The pharmaceutical giant is seeking to expand the use of Spravato, which is currently approved only in combination with oral antidepressants. Approval …
Tag: Investing
FDA expands warning on Diamond Shruumz as illnesses surge
The U.S. Food and Drug Administration has intensified its warning against Diamond Shruumz-brand products as reports of severe illnesses linked to the company’s edibles continue to climb. As of July 15, the FDA reports 69 illnesses across 28 states, with 36 hospitalizations and one death potentially associated with the products. …
Tilray nabs first medical growers license in Germany under new laws
Tilray Brands Inc. (NASDAQ: TLRY) announced Monday that its German subsidiary has received the country’s first new cannabis cultivation license under recently updated regulations, paving a path for its expansion in Europe’s largest economy. The license, which was given to Tilray’s Aphria RX facility, allows cultivation and manufacture of “a …
Pennsylvania cannabis coalition says there’s still a path for adult-use legalization
Despite earlier reports that recreational cannabis legalization in Pennsylvania may have to wait until next year after being left out of the state budget, the spokeswoman of a pro-marijuana coalition said there’s still a window this coming fall for a bill to get through to Gov. Josh Shapiro’s desk. “The …